The move marks the first time the company has recalled its iconic baby powder for possible asbestos contamination, and the first time U.S. regulators ...
News
Lupin largest, most advanced oral solid dosage facility gets EIR from USFDA
The inspection for the oral solid facility at Nagpur closed without any Form 483 observation. The Nagpur facility is Lupin Ltd’s largest and most adva...
Indoco Remedies successfully clears USFDA inspection of CRO facility AnaCipher
Commenting on this development, Aditi Kare Panandikar, Managing Director, Indoco Remedies Limited said, “This achievement is for the fifth time in a r...
Cipla acquires novel anti-infective Elores to further antimicrobial stewardship in critical care in India
Mumbai: Cipla Limited announces the acquisition of a novel and patented anti-infective product, Elores, from Venus Remedies Limited (“VRL”) for the In...
Glenmark Receives USFDA ANDA Approval for Abiraterone Acetate Tablets USP, 250 mg
MUMBAI — Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (U.S....
USFDA red flag to Torrent Pharma’s Indrad facility
New Delhi: The US health regulator has red-flagged Torrent Pharmaceuticals for significant violations of current good manufacturing practice (CGMP) re...
Roche bags FDA approval of Xofluza (baloxavir marboxil) for treatment of acute, uncomplicated influenza
US: Roche today announced that the US Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for XofluzaTM (baloxa...
Teva’s UK arm recalls some batches of Ranitidine: Medicines watchdog
Teva Pharmaceutical’s UK unit has recalled some batches of heartburn medicine Ranitidine, Britain’s medicines watchdog said on Thursday, making it the...
USFDA red flags Glenmark over batch failure investigations at Baddi facility
New Delhi: The US health regulator has red flagged Glenmark Pharmaceuticals for failing to thoroughly investigate violation of manufacturing norms and...
Sun Pharma launches Drizalma Sprinkle in US for treating neuro-psychiatric and pain disorders in patients with swallowing difficulties
New Delhi: Sun Pharmaceutical Industries recently announced that one of its wholly-owned subsidiaries has launched Drizalma Sprinkle™ (duloxetine dela...
